DNTTIP1通过MIDAC介导的BMF的表观遗传沉默驱动白血病发生
Ruolin Xiu1,2, Yuzhu Ma1, Yueying Gao3
1Department of Critical Care Medicine, Department of Hematology, NHC Key Laboratory of Cell Transplantation, Key Laboratory of Hepatosplenic Surgery of Ministry of Education, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Clinical and translational medicine
|January 28, 2026
概括
脱氧核酸转移酶终端相互作用蛋白1 (DNTTIP1) 是急性白血病的关键表观遗传调节剂,通过静止BCL2-修饰因子 (BMF) 来控制白血病细胞存活率. 针对DNTTIP1-HDAC1/2-BMF轴提供了一个有前途的治疗策略.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 由于表观遗传失调,急性白血病存在重大治疗挑战.
- 脱氧核基转移酶终端相互作用蛋白1 (DNTTIP1) 被确定为急性白血病中的新型表观遗传调节剂.
- DNTTIP1在线粒体脱乙酶复合体 (MiDAC) 中起作用,影响白血病细胞存活率.
研究的目的:
- 揭示DNTTIP1在急性白血病中的作用.
- 阐明DNTTIP1在白血病发生中的机理和转化意义.
- 探索针对DNTTIP1通路的治疗策略.
主要方法:
- 在急性白血病模型中利用细胞,生化和遗传乱.
- 综合的多omics分析 (RNA-seq,CUT&Tag,ATAC-seq) 和ChIP-qPCR. 这两种方法都非常有效.
- 进行了与PARP,HDAC和BCL2抑制剂的药物协同作用测试.
主要成果:
- DNTTIP1的枯竭导致BMF促进体过乙化和重新激活,诱导亡.
- 结合HDAC1/2和BCL2抑制显示出协同作用的抗白血病效应.
- 通过抑制DNA损伤修复,PARP抑制增强了这种协同作用,这表明三重组合疗法.
结论:
- DNTTIP1HDAC1/2BMF轴在急性白血病中是一个关键的表观遗传漏洞.
- 这个轴的药理学干扰表明临床前的抗白血病疗效.
- 这些发现为推进向组合疗法进入临床试验提供了理由.
相关概念视频
Epigenetic Regulation
33.7K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.7K
Epigenetic Regulation
3.9K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.9K
Energy to Drive Translocation
2.8K
Mitochondrial protein import is powered by two distinct energy sources: ATP hydrolysis and electrochemical potential across the inner membrane. Newly synthesized precursors are bound by cytosolic chaperones of the Hsp70 family, which guide them to the import receptors on the mitochondrial surface. Utilizing the energy of ATP hydrolysis, Hsp70 chaperones transfer these precursors to the TOM receptors on the mitochondrial outer membrane.
Generally, polypeptides are unfolded by two distinct...
Generally, polypeptides are unfolded by two distinct...
2.8K
M-Cdk Drives Transition Into Mitosis
6.5K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.5K
Receptor-mediated Endocytosis
110.8K
Overview
110.8K
Receptor-mediated Endocytosis
7.7K
Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
7.7K


